Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

The document explains various skin conditions in cats and how to diagnose and treat them.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Fear of hair-related issues causes significant mental distress, especially in high-stress women.

The document concludes that skin and nail changes can indicate various underlying health conditions.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Hair growth dysfunction involves various conditions with limited treatment options.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.